Protyon

Protyon provides molecular modeling and computational predictions to assist clinicians and life science researchers in selecting targeted cancer therapies. The company creates 3D digital models based on the genetic code of cancer mutations to predict how different drugs will interact with a tumor. Their services include clinical decision support for unreported mutations and specialized training courses for medical professionals to understand molecular-level disease drivers.